2015; 9 years ago (2015) (Spun off from Baxter International)
Fate
Acquired by Shire
Headquarters
United States
Key people
Ludwig N. Hantson (president and CEO)
Products
Hematology, Immunology, Pulmonology
Number of employees
16,000[1]
Parent
Takeda Pharmaceutical Company
Website
www.baxalta.com
Baxalta (Bax from the name of its former parent company; alta a Latin adjective meaning 'high' or 'profound'[2]) is a biopharmaceutical company founded on 1 July 2015 after its parent company, Baxter International, spun off biopharmaceutical division.[1] The company began its operation with a revenue of $6 billion,[3] and is now a subsidiary of Takeda Pharmaceutical Company.
^ abBen Reynolds. "Baxalta: A Rare Undervalued Biopharmaceutical Company". cnafinance.com. Archived from the original on 2015-07-24. Retrieved 2015-07-23.
Baxalta (Bax from the name of its former parent company; alta a Latin adjective meaning 'high' or 'profound') is a biopharmaceutical company founded on...
Japan. In 2015, Baxter split-off its haemophilia sector to create Baxalta. In 2016 Baxalta was acquired by Shire plc for $32bn. Immuno AG: Baxter purchased...
Retrieved 2015-12-11. "David Meek, president of oncology division of Baxalta". Baxalta. Retrieved 2015-07-11. "Ipsen Names David Meek CEO". Nasdaq. Retrieved...
of therapies for the treatment of haemophilia. Bioverativ competes with Baxalta (acquired by Shire Plc in 2016), Pfizer and Novo Nordisk. The company traded...
Baxter International Inc. and the bio-pharmaceuticals company is named Baxalta and spun-off as a new public company that showed on trading boards as of...
Eastern European headquarters in Vienna, including Hewlett-Packard, Henkel, Baxalta, and Siemens. Annually since 2004, approximately 8,300 new companies have...
metastatic colorectal cancer. It was developed by Cytokine PharmaSciences and Baxalta, which was purchased by Shire Pharmaceuticals. A phase I/II trial in patients...
Antihemophilic Factor VIII for the treatment of patients with hemophilia A. (Baxalta, 2015) Irinotecan liposome (Onivyde) – PEGylated liposomal irinotecan hydrochloride...
Archived from the original on 2016-01-29. Retrieved 2016-01-31. "Shire, Baxalta Complete $32B Merger". 3 June 2016. "SoftBank completes $31 billion acquisition...
technology Enhanze to other biopharmaceutical companies, including Roche, Baxalta, Pfizer, Janssen, AbbVie, Bristol Myers Squibb and Lilly. Since January...
Arlington, Virginia. Amgen, the world's largest biotechnology company, and Baxalta are located near Cal Lutheran and hire graduates each year. As of 1995...
billion acquisition of German private company Wirtgen. He advised on Baxalta's $38 billion cross-border sale to Shire. Over the course of his career...
Global Information
